Clinical Trial Update: Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section [Phase 4]

View source ↗

Summary

Phase 4 trial comparing carbetocin to Syntocinon for prevention of postpartum hemorrhage in cardiac patients undergoing cesarean section.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Diseases
• Postpartum Hemorrhage

Drugs mentioned

• Carbetocin (carbetocin)
• Syntocinon (oxytocin)

Snippet

Sponsor: Cairo University | Conditions: Adverse Effect of Oxytocic Drugs | Phase 4 | Status: UNKNOWN